Study Evaluating Venlafaxine ER in Adults With Panic Disorder
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the efficacy, safety, and tolerability of
a flexible dose of venlafaxine extended-release (ER) capsules administered for 10 weeks in
the treatment of adult outpatients with panic disorder (PD) in a placebo-controlled phase III
study.